Targeting mitochondrial transcription termination factor MTERF3 induces mitochondrial dysfunction and inhibits the proliferation via activating ROS-dependent p38 MAPK pathway in hepatocellular carcinoma. Here, MTERF3 is linked to hepatocellular carcinoma.